254 related articles for article (PubMed ID: 29740048)
1. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Grindel BJ; Martinez JR; Tellman TV; Harrington DA; Zafar H; Nakhleh L; Chung LW; Farach-Carson MC
Sci Rep; 2018 May; 8(1):7262. PubMed ID: 29740048
[TBL] [Abstract][Full Text] [Related]
2. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Grindel BJ; Martinez JR; Pennington CL; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Matrix Biol; 2014 Jun; 36():64-76. PubMed ID: 24833109
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Tellman TV; Cruz LA; Grindel BJ; Farach-Carson MC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809984
[TBL] [Abstract][Full Text] [Related]
4. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
[TBL] [Abstract][Full Text] [Related]
6. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.
Farach-Carson MC; Brown AJ; Lynam M; Safran JB; Carson DD
Matrix Biol; 2008 Mar; 27(2):150-60. PubMed ID: 17997086
[TBL] [Abstract][Full Text] [Related]
8. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.
Brasil da Costa FH; Lewis MS; Truong A; Carson DD; Farach-Carson MC
PLoS One; 2020; 15(5):e0230354. PubMed ID: 32413029
[TBL] [Abstract][Full Text] [Related]
9. The extracellular matrix proteoglycan perlecan facilitates transmembrane semaphorin-mediated repulsive guidance.
Cho JY; Chak K; Andreone BJ; Wooley JR; Kolodkin AL
Genes Dev; 2012 Oct; 26(19):2222-35. PubMed ID: 23028146
[TBL] [Abstract][Full Text] [Related]
10. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.
Barlak N; Capik O; Kilic A; Sanli F; Aytatli A; Yazici A; Karatas EA; Ortucu S; Karatas OF
Cell Biol Int; 2021 May; 45(5):1082-1090. PubMed ID: 33501702
[TBL] [Abstract][Full Text] [Related]
12. Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model.
Hartman O; Zhang C; Adams EL; Farach-Carson MC; Petrelli NJ; Chase BD; Rabolt JF
Biomaterials; 2010 Jul; 31(21):5700-18. PubMed ID: 20417554
[TBL] [Abstract][Full Text] [Related]
13. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
Cruz LA; Tellman TV; Farach-Carson MC
Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
[TBL] [Abstract][Full Text] [Related]
14. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
15. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
[TBL] [Abstract][Full Text] [Related]
16. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
[TBL] [Abstract][Full Text] [Related]
17. Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling.
Walker HA; Whitelock JM; Garl PJ; Nemenoff RA; Stenmark KR; Weiser-Evans MC
Mol Biol Cell; 2003 May; 14(5):1941-52. PubMed ID: 12802066
[TBL] [Abstract][Full Text] [Related]
18. Perlecan and tumor angiogenesis.
Jiang X; Couchman JR
J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
[TBL] [Abstract][Full Text] [Related]
19. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.
Savorè C; Zhang C; Muir C; Liu R; Wyrwa J; Shu J; Zhau HE; Chung LW; Carson DD; Farach-Carson MC
Clin Exp Metastasis; 2005; 22(5):377-90. PubMed ID: 16283481
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase functions downstream of Sema3A signaling during axonal remodeling.
Chacón MR; Fernández G; Rico B
Mol Cell Neurosci; 2010 May; 44(1):30-42. PubMed ID: 20159040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
